🇺🇸 Intravenous bumetanide TID in United States

Intravenous bumetanide TID (Intravenous bumetanide TID) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intravenous bumetanide TID in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intravenous bumetanide TID approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intravenous bumetanide TID in United States?

Vrije Universiteit Brussel is the originator. The local marketing authorisation holder may differ — check the official source linked above.